| Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention (NCT02423915) | M.D. Anderson Cancer Center | 2015-07-30 |
| Study of E7046 in Subjects With Selected Advanced Malignancies (NCT02540291) | Eisai Inc. | 2015-07-30 |
| Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment (NCT02653014) | KBP Biosciences | 2015-07-29 |
| A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer (NCT02443324) | Eli Lilly and Company | 2015-07-29 |
| Mechanism of Allogeneic UCB Therapy in Cerebral Palsy (NCT03130816) | Bundang CHA Hospital | 2015-07-29 |
| A Study of Multiple Doses of ALXN1210 in Healthy Adult Participants (NCT05288673) | Alexion Pharmaceuticals, Inc. | 2015-07-28 |
| Multiple Ascending Dose Study of HM12470 in Type 1 and Type 2 Diabetes Mellitus (NCT03332849) | Hanmi Pharmaceutical Company Limited | 2015-07-28 |
| Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas (NCT02313272) | H. Lee Moffitt Cancer Center and Research Institute | 2015-07-28 |
| A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors (NCT02471846) | Genentech, Inc. | 2015-07-28 |
| Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies (NCT02122081) | Sumithira Vasu | 2015-07-27 |
| A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT02406742) | Celgene | 2015-07-27 |
| Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study) (NCT02507427) | Seoul National University Hospital | 2015-07-26 |
| Pharmacokinetic Study of the Association of Amoxicillin / Clavulanic Acid to Obese Adults (NCT02571959) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2015-07-24 |
| MEDI9447 Alone and in Combination With MEDI4736 in Adult Participants With Select Advanced Solid Tumors. (NCT02503774) | MedImmune LLC | 2015-07-24 |
| A Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults (NCT02491463) | GlaxoSmithKline | 2015-07-23 |
| The Pharmacokinetic Study of WH-1 Ointment in Subjects With Chronic Diabetic Foot Ulcers (NCT02353273) | Oneness Biotech Co., Ltd. | 2015-07-22 |
| A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM) (NCT02431208) | Hoffmann-La Roche | 2015-07-22 |
| Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer (NCT02402920) | M.D. Anderson Cancer Center | 2015-07-22 |
| WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck (NCT02508246) | University of Washington | 2015-07-22 |
| Safety Tolerability and Efficacy of Intravitreal LMG324 in the Treatment of Neovascular Age-Related Macular Degeneration (NCT02398500) | Alcon Research | 2015-07-22 |
| A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors (NCT02501096) | Eisai Inc. | 2015-07-22 |
| Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208) | National Cancer Institute (NCI) | 2015-07-22 |
| A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer (NCT02489201) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2015-07-21 |
| A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab (NCT02518958) | EpicentRx, Inc. | 2015-07-21 |
| A Study to Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals (NCT02568332) | University of Oxford | 2015-07-21 |
| Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B... (NCT02511054) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-21 |
| Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers (NCT02484417) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-21 |
| Bioavailability of DFN-15 at 3 Different Doses vs. Comparator and to Determine Dose-proportionality of DFN-15 in Fasting Healthy Adults (NCT03051685) | Dr. Reddy's Laboratories Limited | 2015-07-20 |
| Effect of Food on BIA 5-1058 (NCT04991155) | Bial - Portela C S.A. | 2015-07-20 |
| Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome (NCT02365506) | Gilead Sciences | 2015-07-20 |
| MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC) (NCT02422381) | Providence Health & Services | 2015-07-20 |
| Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma (NCT02504359) | OHSU Knight Cancer Institute | 2015-07-20 |
| A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast Cancer (NCT02423902) | Alaunos Therapeutics | 2015-07-18 |
| Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis (NCT02502188) | Celgene | 2015-07-17 |
| Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients (NCT02479230) | Joseph Baar, MD, PhD | 2015-07-17 |
| Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) (NCT02393794) | Priyanka Sharma | 2015-07-17 |
| A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 (NCT02482441) | OncoMed Pharmaceuticals, Inc. | 2015-07-16 |
| Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion (NCT02231658) | Profil Institut für Stoffwechselforschung GmbH | 2015-07-16 |
| Effects of Aromatherapy on Anxiety in Invasive Radiologic Procedure (NCT03090750) | Wake Forest University Health Sciences | 2015-07-16 |
| Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors (NCT03295084) | Dorte Nielsen | 2015-07-15 |
| Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors (NCT02415153) | National Cancer Institute (NCI) | 2015-07-14 |
| Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas (NCT02503423) | Taiho Oncology, Inc. | 2015-07-14 |
| Resveratrol and Cardiovascular Health in the Elderly (NCT01842399) | National Institute on Aging (NIA) | 2015-07-14 |
| Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy (NCT02499224) | CellabMED | 2015-07-13 |
| Safety and Efficacy Study of Ulocuplumab and Nivolumab in Subjects With Solid Tumors (NCT02472977) | Bristol-Myers Squibb | 2015-07-13 |
| Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disorders (NCT02502903) | Bioverativ, a Sanofi company | 2015-07-13 |
| Evaluation of the Combination of Romidepsin and Carfilzomib in Relapsed/Refractory Peripheral T Cell Lymphoma Patients (NCT03141203) | University of Birmingham | 2015-07-13 |
| VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption (NCT02471326) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-07-13 |
| TVEC and Preop Radiation for Sarcoma (4 ml Dose) (NCT02453191) | University of Iowa | 2015-07-13 |
| Pharmacokinetics Study of GSK1265744 in Subjects With Severe Renal Impairment (NCT02354937) | ViiV Healthcare | 2015-07-13 |
| Clinical Trial Study About Human Adipose-Derived Stem Cells in the Liver Cirrhosis (NCT02297867) | Gwo Xi Stem Cell Applied Technology Co., Ltd. | 2015-07-13 |
| A Study of JNJ-54767414 (Daratumumab) in Combination With Bortezomib and Dexamethasone (D-Vd) in Japanese Participants With Relapsed or Refractory Multiple Myeloma (NCT02497378) | Janssen Pharmaceutical K.K. | 2015-07-10 |
| A Study of an Investigational Drug, ALN-AAT, in Healthy Adult Subjects and Patients With ZZ Type Alpha-1 Antitrypsin Deficiency Liver Disease (NCT02503683) | Alnylam Pharmaceuticals | 2015-07-09 |
| Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers (NCT02703181) | GlaxoSmithKline | 2015-07-09 |
| A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer (NCT02448771) | Dana-Farber Cancer Institute | 2015-07-09 |
| Postoperative Pain Control With Lipossomic Extended Release Bupivacaine (NCT03560362) | University of Tennessee | 2015-07-09 |
| Lenalidomide and AT-101 in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia (NCT01003769) | Mayo Clinic | 2015-07-09 |
| SF1126 for Patients With Relapsed or Refractory Neuroblastoma (NCT02337309) | New Approaches to Neuroblastoma Therapy Consortium | 2015-07-09 |
| Intratumoral Injections of LL37 for Melanoma (NCT02225366) | M.D. Anderson Cancer Center | 2015-07-08 |
| BI 894999 First in Human Dose Finding Study in Advanced Malignancies (NCT02516553) | Boehringer Ingelheim | 2015-07-08 |
| Phase I Dose Escalation of i.v. BI 836909 Monotherapy in Last Line Multiple Myeloma Patients (NCT02514239) | Boehringer Ingelheim | 2015-07-08 |
| A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI) (NCT02480881) | ViiV Healthcare | 2015-07-07 |
| PK Study of Anti-TB Drugs (NCT02457208) | University of Oxford | 2015-07-07 |
| A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations (NCT02492776) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-07-07 |
| A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream (NCT02411162) | Stiefel, a GSK Company | 2015-07-07 |
| A Open-label, Drug-Drug Interaction With Maraviroc (DDI) (NCT02480894) | ViiV Healthcare | 2015-07-07 |
| Mesenchymal Stem Cells Transplantation in Newly Diagnosed Type-1 Diabetes Patients (NCT04078308) | Royan Institute | 2015-07-06 |
| Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery (NCT02420847) | M.D. Anderson Cancer Center | 2015-07-03 |
| A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma (NCT01614197) | Therapeutic Advances in Childhood Leukemia Consortium | 2015-07-03 |
| A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT02556892) | Janssen Pharmaceutical K.K. | 2015-07-03 |
| Study Evaluating Hemay020 In Subjects With Advanced Solid Cancer (NCT02467569) | Tianjin Hemay Pharmaceutical Co., Ltd | 2015-07-03 |
| A Study of TCR-Redirected T Cell Infusion in Subject With Recurrent HBV-related HCC Post Liver Transplantation (NCT02719782) | Lion TCR Pte. Ltd. | 2015-07-02 |
| A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors (NCT02452424) | Daiichi Sankyo | 2015-07-02 |
| Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer (NCT02475213) | MacroGenics | 2015-07-01 |
| Bioequivalence Study of Sorafenib Tablet and Nexavar (NCT02599337) | Yabao Pharmaceutical Group | 2015-07-01 |
| Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide (NCT02515396) | Moerae Matrix, Inc. | 2015-07-01 |
| A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935 (NCT02497235) | Takeda | 2015-07-01 |
| First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979 (NCT02509117) | Pfizer | 2015-07-01 |
| HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors (NCT02232243) | Peng Wang, MD PhD | 2015-07-01 |
| Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction (NCT02344849) | Pharmicell Co., Ltd. | 2015-07-01 |
| Treatment of Chronic Itch in Atopic Dermatitis (Eczema): Nerve Function (NCT02268448) | University of Minnesota | 2015-07-01 |
| CD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell Malignancy (NCT02537977) | Shanghai Tongji Hospital, Tongji University School of Medicine | 2015-07-01 |
| Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer (NCT03001544) | Translational Sciences, Inc. | 2015-07-01 |
| An Open-label, Single Dose, Parallel Design, Phase 1 Clinical Study of LCB01-0371 (NCT02529241) | LigaChem Biosciences, Inc. | 2015-07-01 |
| Study of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT02464657) | M.D. Anderson Cancer Center | 2015-07-01 |
| A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers (NCT02545439) | Alkermes, Inc. | 2015-07-01 |
| Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML) (NCT02343939) | Gilead Sciences | 2015-07-01 |
| Phase 1 Study of NPT200-11 in Healthy Subjects (NCT02606682) | Neuropore Therapies Inc. | 2015-07-01 |
| LEO 32731 - A Phase I Study in Healthy Subjects (NCT02514694) | LEO Pharma | 2015-07-01 |
| Intraarterial Stem Cells in Subacute Ischemic Stroke (NCT03080571) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2015-07-01 |
| Safety and Efficacy Study of Orally Administered DS102 in Healthy Subjects (NCT02673593) | DS Biopharma | 2015-07-01 |
| Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors (NCT02684318) | Poveda, Andrés, M.D. | 2015-07-01 |
| A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers (NCT02565368) | Chong Kun Dang Pharmaceutical | 2015-07-01 |
| Cromolyn Detection of Silent Aspiration (NCT01841307) | University of California, San Francisco | 2015-07-01 |
| Safety, Blood Levels and Effects of MGB-BP-3 (NCT02518607) | MGB Biopharma Limited | 2015-07-01 |
| REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts (NCT01496209) | Cedars-Sinai Medical Center | 2015-07-01 |
| Pilot Study of OXP001(2) and Brufen in Healthy Subjects (NCT02521207) | Oxford Pharmascience Ltd | 2015-07-01 |
| A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer (NCT02244463) | Dana-Farber Cancer Institute | 2015-07-01 |
| Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 (NCT02523391) | Xention Ltd | 2015-07-01 |
| The Safety and Immunogenicity of the DNA-GTU Vaccine Administered to HIV-infected Patients on ART vs Placebo (NCT02457689) | Imperial College London | 2015-07-01 |